 |
|
Track 1: Public Health and Basic Sciences for Emerging and Major Viral Infectious Diseases
-Understanding the Complex Dynamics of Viral Epidemics and Development |
|
| |
| Session 1: Global Plans for Responding to Emerging and Re-emerging Viral Infectious Diseases |
| This session will cover the following potential topics: |
| |
|
Threat of Emerging Viral Infectious Diseases on Global Health, Socio-economic and Political Factors |
|
Global Plans for Responding to Emerging and Re-emerging Viral Infectious Diseases |
|
Current Trend and Characteristics of worldwide Viral Infectious Pandemic |
|
Virus Diseases in Developing Countries |
|
Trend on Transition of Communicable Diseases |
|
Strategies for Epidemic Intelligence, Verification, Risk Assessment and Responses |
|
Improved Surveillance and Early Warning Systems |
| |
|
| You can propose your current innovative technologies for antiviral research or drug discovery here |
|
| |
| Session 2: Accessibilities to Multi-Lateral Cooperative Antiviral Programs |
| This session will cover the following potential topics: |
| |
|
Enhance Prevention & Control Education of Viral Infectious Diseases |
|
Viral Infectious Diseases Emergency Response Mechanism and Control Theories |
|
Strengthen the Infrastructure and the Preparedness for Known and Unexpected Risks |
|
Quality Management for the leaders of Infectious Disease Surveillance of International Institutions |
|
Understanding Legal Issues for Viral Infectious Diseases |
|
Relations of Policy Makers and Public Awareness on Emerging Viral Infectious Diseases |
|
Public Health and Community-Acquired Infections |
|
Emerging Viral infectious Diseases |
|
Resources Available When Emergency Arise |
|
Virus Detection Technologies for Biodefense |
|
Roles of Supportive Philanthropy, NGOs and Private Foundations |
|
Introduction to Who' s who in Antiviral Industries |
| |
|
| You can propose your current innovative technologies for antiviral research or drug discovery here |
|
| |
| Session 3: Etiology and Epidemiology of Viral Infections |
| This session will cover the following potential topics: |
| |
|
Current Advances in Pathogenesis of Major Viral Infectious Diseases |
|
Antiviral Pharmacokinetics, Pharmacodynamics and General Pharmacology |
|
Mechanisms of Action and Viral Resistance |
|
Emerging virus infection and intervention strategies |
|
Molecular Epidemiology of Resistance Genes, Virus Strains and Serotypes |
|
Epidemiology of RNA and DNA Based Viruses |
|
Introduction to Pestilence, Plague, Bioterrorism |
|
Viral Bioterrorism and Antiviral Countermeasures |
|
The Emergence of Pandemic Influenza A in regard to Bioterrorist Versus Mother Nature |
| |
|
| You can propose your current innovative technologies for antiviral research or drug discovery here |
|
| |
| Session 4: Virology, Population and Evolutionary Biology |
| This session will cover the following potential topics: |
| |
|
Molecular Biology of Virus |
|
Molecular Virology |
|
Molecular Typing |
|
Structure and Assembly: Non-Enveloped Viruses |
|
Neurovirology |
|
Oncovirology |
|
Hepatitis |
|
Virology non-HIV/Non-Hepatitis |
|
Immunology in Antiviral Research |
|
Viral Zoonoses |
|
Virus Taxonomy |
| |
|
| You can propose your current innovative technologies for antiviral research or drug discovery here |
|
| |
| Session 5: Informatics, Biostatistics and Mathematical Modeling for Antiviral Researches |
| This session will cover the following potential topics: |
| |
|
Internet and Electronic Resources |
|
Viral Bioinformatics |
|
Molecular epidemiology (especially as virus "evolves" and spreads) |
|
Basic epidemiology /natural history studies of the virus/host/vector |
|
Establishment of important vector and host components of flavivirus cycling |
|
Development and Testing of New and Alternative Virus Control Methods |
|
Definition of Viral Epizootic/Enzootic Maintenance Mechanisms |
|
Development and Assessment of Modern Methods to Predict Emergence and Extent of Spread of Viral Pathogens |
|
Establishment/supplementation of Overseas Research programs in areas of intense antiviral activities |
| |
|
| You can propose your current innovative technologies for antiviral research or drug discovery here |
|
| |
